Impact of extracellular matrix scaffold on driveline infection rate in patients with left ventricular assist devices
Patients who received ECM implantation at the time of LVAD implantation had a significantly lower rate of DLIs than patients who did not receive ECM around the driveline. These results suggest that ECM may be a valuable adjunctive strategy to reduce the risk of DLIs in LVAD recipients.
Authors
- Manish Kumar Patel (ORCID: https://orcid.org/0000-0001-5250-1008)
- Mateja K. Ježovnik (ORCID: https://orcid.org/0000-0002-5317-0148)
- Biswajit Kar (ORCID: https://orcid.org/0000-0003-2686-5814)
- Ismael A. Salas de Armas (ORCID: https://orcid.org/0000-0001-8109-6574)
- Maria Aponte (ORCID: https://orcid.org/0000-0001-6770-0595)
- Jayeshkumar Patel
- Mehmet H. Akay (ORCID: https://orcid.org/0009-0009-0414-5550)
- Marwan Jumean (ORCID: https://orcid.org/0000-0001-8768-190X)
- Igor D. Gregorič (ORCID: https://orcid.org/0000-0003-2290-2964)
- Rajko Radovancevic
Institutions
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- JTCVS Open
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1016/j.xjon.2025.03.029
- Primary Topic
- Tissue Engineering and Regenerative Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00